{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:43:28Z","timestamp":1771001008058,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,6,30]],"date-time":"2000-06-30T00:00:00Z","timestamp":962323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,6,30]],"date-time":"2000-06-30T00:00:00Z","timestamp":962323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2000,7,1]]},"DOI":"10.1038\/sj.mp.4000728","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:52:28Z","timestamp":1031165548000},"page":"357-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Neurotransmitter transporters: fruitful targets for CNS drug discovery"],"prefix":"10.1038","volume":"5","author":[{"given":"L","family":"Iversen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,6,30]]},"reference":[{"key":"BF4000728_CR1","first-page":"251","volume":"127","author":"J Axelrod","year":"1959","unstructured":"Axelrod J, Weil-Malherbe H, Tomchick R . The physiological disposition of\u20023H-epinephrine and its metabolite metanephrine J Pharmacol Exp Ther 1959; 127: 251\u2013256","journal-title":"J Pharmacol Exp Ther"},{"key":"BF4000728_CR2","first-page":"193","volume":"132","author":"LG Whitby","year":"1961","unstructured":"Whitby LG, Axelrod J, Weil-Malherbe H . The fate of\u20023H-norepinephrine in animals J Pharmacol Exp Ther 1961; 132: 193\u2013201","journal-title":"J Pharmacol Exp Ther"},{"key":"BF4000728_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/189066a0","volume":"189","author":"G Hertting","year":"1961","unstructured":"Hertting G, Axelrod J, Kopin IJ, Whitby LG . Lack of uptake of catecholamines after chronic denervation of sympathetic nerves Nature 1961; 189: 66","journal-title":"Nature"},{"key":"BF4000728_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/192172a0","volume":"192","author":"G Hertting","year":"1961","unstructured":"Hertting G, Axelrod J . Fate of tritiated noradrenaline at the sympathetic nerve endings Nature 1961; 192: 172\u2013173","journal-title":"Nature"},{"key":"BF4000728_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1476-5381.1971.tb07066.x","volume":"41","author":"LL Iversen","year":"1971","unstructured":"Iversen LL . Role of transmitter uptake mechanisms in synaptic neurotransmission Br J Pharmacol 1971; 41: 571\u2013591","journal-title":"Br J Pharmacol"},{"key":"BF4000728_CR6","first-page":"381","volume-title":"Handbook of Psychopharmacology","author":"LL Iversen","year":"1975","unstructured":"Iversen LL . Uptake processes for biogenic amines. In: Iversen L, Iversen S, Snyder S (eds) Handbook of Psychopharmacology Vol 3: Plenum Press: New York 1975; pp381\u2013432"},{"key":"BF4000728_CR7","first-page":"439","volume":"51","author":"J Masson","year":"1999","unstructured":"Masson J, Sagn\u00e9 C, Hamon M, El Mestikawy S . Neurotransmitter transporters in the central nervous system Pharmacol Rev 1999; 51: 439\u2013464","journal-title":"Pharmacol Rev"},{"key":"BF4000728_CR8","doi-asserted-by":"crossref","first-page":"11859","DOI":"10.1016\/S0021-9258(17)39110-X","volume":"260","author":"R Radian","year":"1986","unstructured":"Radian R, Kanner BI . Reconstitution and purification of the sodium-and chloride-coupled \u03b3-aminobutyric acid transport glycoprotein from rat brain J Biol Chem 1986; 260: 11859\u201311865","journal-title":"J Biol Chem"},{"key":"BF4000728_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/350350a0","volume":"350","author":"T Pacholczyk","year":"1991","unstructured":"Pacholczyk T, Blakely RD, Amara SG . Expression cloning of an antidepressant-sensitive noradrenaline transporter Nature 1991; 350: 350\u2013353","journal-title":"Nature"},{"key":"BF4000728_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/1557","volume":"1","author":"D Gr\u00fcndemann","year":"1998","unstructured":"Gr\u00fcndemann D, Schechinger B, Rappold GA, Sch\u00f6mig E . Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter Nature Neurosci 1998; 1: 349\u2013351","journal-title":"Nature Neurosci"},{"key":"BF4000728_CR11","first-page":"1867","volume":"135","author":"S Wahle","year":"1996","unstructured":"Wahle S, Stoffel W . Membrane topology of the high affinity L-glutamate transporter (GLAST-1) of the central nervous system J Biol Chem 1996; 135: 1867\u20131877","journal-title":"J Biol Chem"},{"key":"BF4000728_CR12","doi-asserted-by":"publisher","first-page":"12737","DOI":"10.1073\/pnas.95.22.12737","volume":"95","author":"MP Kavanaugh","year":"1998","unstructured":"Kavanaugh MP . Neurotransmitter transport: models in flux Proc Natl Acad Sci USA 1998; 95: 12737\u201312738","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4000728_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1126\/science.133.3450.383","volume":"133","author":"J Axelrod","year":"1961","unstructured":"Axelrod J, Whitby L, Hertting G . Effect of psychotropic drugs on the uptake of\u20023H-norepinephrine by tissues Science 1961; 133: 383","journal-title":"Science"},{"key":"BF4000728_CR14","volume-title":"The Antidepressant Era","author":"D Healy","year":"1998","unstructured":"Healy D . The Antidepressant Era Harvard University Press: Boston 1998"},{"key":"BF4000728_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0024-3205(95)00209-O","volume":"57","author":"DT Wong","year":"1995","unstructured":"Wong DT, Bymaster FP, Engleman EA . Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug. Twenty years since its first publication Life Sci 1995; 57: 411\u2013441","journal-title":"Life Sci"},{"key":"BF4000728_CR16","first-page":"1305","volume":"283","author":"MJ Owens","year":"1997","unstructured":"Owens MJ, Morgan WN, Plott SJ, Nemeroff CB . Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites J Pharmacol Exp Ther 1997; 283: 1305\u20131322","journal-title":"J Pharmacol Exp Ther"},{"key":"BF4000728_CR17","first-page":"24","volume":"2356","author":"Z Chustecka","year":"1998","unstructured":"Chustecka Z . New challenges in the antidepressant market SCRIP 1998; 2356: 24\u201325","journal-title":"SCRIP"},{"issue":"Suppl 1","key":"BF4000728_CR18","first-page":"S18","volume":"22","author":"DJ Heal","year":"1998","unstructured":"Heal DJ, Aspley S, Prow MR, Jackson HC, Martin KF, Cheetham SC . Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine Int J Obes Relat Metab Disord 1998; 22 Suppl 1: S18\u2013S28","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF4000728_CR19","unstructured":"Montgomery S . Reboxetine: additional benefits to the depressed patient J Psychopharmacol 11 Suppl 4: S9\u2013S15"},{"key":"BF4000728_CR20","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0006-3223(99)00127-4","volume":"46","author":"KJ Ressler","year":"1999","unstructured":"Ressler KJ, Nemeroff CB . Role of norepinephrine in the pathophysiology and treatment of mood disorders Biol Psychiatry 1999; 46: 1219\u20131233","journal-title":"Biol Psychiatry"},{"key":"BF4000728_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","author":"J Schildkraut","year":"1965","unstructured":"Schildkraut J . The catecholamine hypothesis of affective disorders: a review of supporting evidence Am J Psychiatry 1965; 122: 509\u2013522","journal-title":"Am J Psychiatry"},{"key":"BF4000728_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1476-5381.1996.tb15162.x","volume":"117","author":"S Al-Damluji","year":"1996","unstructured":"Al-Damluji S, Kopin IJ . Functional properties of the uptake of amines in immortalised peptidergic neurones (transport-P) Br J Pharmacol 1996; 117: 111\u2013118","journal-title":"Br J Pharmacol"},{"key":"BF4000728_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1476-5381.1996.tb15265.x","volume":"117","author":"S Al-Damluji","year":"1996","unstructured":"Al-Damluji S, Kopin IJ . Binding and competitive inhibition of amine uptake at postsynaptic neurones (transport-P) by tricyclic antidepressants Br J Pharmacol 1996; 117: 811\u2013816","journal-title":"Br J Pharmacol"},{"key":"BF4000728_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/379606a0","volume":"379","author":"B Giros","year":"1996","unstructured":"Giros B, Jaber M, Jones SR, Wightman RM, Caron MG . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 1996; 379: 606\u2013612","journal-title":"Nature"},{"key":"BF4000728_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/381","volume":"1","author":"BA Rocha","year":"1998","unstructured":"Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B et al. Cocaine self-administration on dopamine transporter knockout mice Nature Neurosci 1998; 1: 132\u2013137","journal-title":"Nature Neurosci"},{"key":"BF4000728_CR26","doi-asserted-by":"publisher","first-page":"7699","DOI":"10.1073\/pnas.95.13.7699","volume":"95","author":"I Sora","year":"1998","unstructured":"Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R et al. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice Proc Natl Acad Sci USA 1998; 95: 7699\u20137704","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4000728_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1358\/dof.1999.024.02.474033","volume":"24","author":"A Graul","year":"1999","unstructured":"Graul A, Castaner J . Brasofensine sulfate: antiparkinsonian dopamine reuptake inhibitor Drugs of the Future 1999; 24: 128\u2013132","journal-title":"Drugs of the Future"},{"key":"BF4000728_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0166-4328(97)00175-7","volume":"94","author":"MV Solanto","year":"1998","unstructured":"Solanto MV . Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration Behav Brain Res 1998; 94: 127\u2013152","journal-title":"Behav Brain Res"},{"key":"BF4000728_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1126\/science.283.5400.397","volume":"283","author":"RR Gainetdinov","year":"1999","unstructured":"Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG . Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 1999; 283: 397\u2013401","journal-title":"Science"},{"key":"BF4000728_CR30","first-page":"993","volume":"56","author":"EH Cook","year":"1995","unstructured":"Cook EH, Stein MA, Krasowski MD, Cox W, Olkon DM, Kieffer JE et al. Association of attention-deficit disorder and the dopamine transporter gene Am J Hum Genet 1995; 56: 993\u2013998","journal-title":"Am J Hum Genet"},{"key":"BF4000728_CR31","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1345\/aph.18053","volume":"32","author":"MS Luer","year":"1998","unstructured":"Luer MS, Rhoney-Denise H . Tiagabine: a novel antiepileptic drug Annal Pharmacother 1998; 32: 1173\u20131180","journal-title":"Annal Pharmacother"},{"key":"BF4000728_CR32","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","volume":"277","author":"M Beltramo","year":"1997","unstructured":"Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D . Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 1997; 277: 1094\u20131097","journal-title":"Science"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4000728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4000728","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4000728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:17:33Z","timestamp":1648786653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6,30]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,7,1]]}},"alternative-id":["BF4000728"],"URL":"https:\/\/doi.org\/10.1038\/sj.mp.4000728","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6,30]]},"assertion":[{"value":"10 December 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}